SCHEMBL17827434

SCHEMBL17827434

c1ccc(C2(c3ccc(-c4cccc(N(c5ccc6c(c5)oc5ccccc56)c5ccc6c(c5)oc5ccccc56)c4)cc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
LMNA P02545 1/20 0.33
OPRK1 P41145 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
AHR P35869 2/20 0.33
ALOX5 P09917 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HCRTR1 O43613 1/20 0.32
PLA2G10 O15496 1/20 0.31
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21239192 0.98 KDM4E (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL22036282 0.96 AHR (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL17827438 0.96 PLA2G2A (0.35) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL19596050 0.95 KDM4E (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL24156397 0.95 KDM4E (0.34) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL22182347 0.95 PDK2 (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL22134217 0.94 AHR (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL17827464 0.94 MMP12 (0.33) KDM4EMEN1MAPTKMT2AMMP12
SCHEMBL22403540 0.94 AHR (0.33) KDM4EMEN1MAPTKMT2ALMNA
SCHEMBL17827459 0.94 MMP12 (0.33) KDM4EMEN1MAPTKMT2AMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME AOC2, SAT1, ODC1 KDM4E 595/4885MEN1 507/4885MAPT 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.